supreme antacid

Generic: calcium carbonate, magnesium hydroxide

Labeler: family dollar services inc
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name supreme antacid
Generic Name calcium carbonate, magnesium hydroxide
Labeler family dollar services inc
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

calcium carbonate 400 mg/5mL, magnesium hydroxide 135 mg/5mL

Manufacturer
FAMILY DOLLAR SERVICES INC

Identifiers & Regulatory

Product NDC 55319-624
Product ID 55319-624_43f5b769-711e-58cf-e063-6394a90a5674
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M001
Listing Expiration 2026-12-31
Marketing Start 2017-06-01

Pharmacologic Class

Classes
blood coagulation factor [epc] calcium [cs] calculi dissolution agent [epc] cations divalent [cs] increased coagulation factor activity [pe] increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] inhibition small intestine fluid/electrolyte absorption [pe] magnesium ion exchange activity [moa] osmotic activity [moa] osmotic laxative [epc] phosphate binder [epc] phosphate chelating activity [moa] stimulation large intestine fluid/electrolyte secretion [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55319624
Hyphenated Format 55319-624

Supplemental Identifiers

RxCUI
237865
UNII
H0G9379FGK NBZ3QY004S

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name supreme antacid (source: ndc)
Generic Name calcium carbonate, magnesium hydroxide (source: ndc)
Application Number M001 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 400 mg/5mL
  • 135 mg/5mL
source: ndc
Packaging
  • 355 mL in 1 BOTTLE (55319-624-12)
source: ndc

Packages (1)

55319-624-12 355 mL in 1 BOTTLE (55319-624-12)

Ingredients (2)

calcium carbonate (400 mg/5mL) magnesium hydroxide (135 mg/5mL)

Linked Drug Pages (1)

SUPREME ANTACID ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "43f5b769-711e-58cf-e063-6394a90a5674", "openfda": {"unii": ["H0G9379FGK", "NBZ3QY004S"], "rxcui": ["237865"], "spl_set_id": ["5e996df3-25a4-b259-e053-2a91aa0a4311"], "manufacturer_name": ["FAMILY DOLLAR SERVICES INC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "355 mL in 1 BOTTLE (55319-624-12)", "package_ndc": "55319-624-12", "marketing_start_date": "20170801"}], "brand_name": "SUPREME ANTACID", "product_id": "55319-624_43f5b769-711e-58cf-e063-6394a90a5674", "dosage_form": "SUSPENSION", "pharm_class": ["Blood Coagulation Factor [EPC]", "Calcium [CS]", "Calculi Dissolution Agent [EPC]", "Cations", "Divalent [CS]", "Increased Coagulation Factor Activity [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Phosphate Binder [EPC]", "Phosphate Chelating Activity [MoA]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "55319-624", "generic_name": "calcium carbonate, magnesium hydroxide", "labeler_name": "FAMILY DOLLAR SERVICES INC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "SUPREME ANTACID", "active_ingredients": [{"name": "CALCIUM CARBONATE", "strength": "400 mg/5mL"}, {"name": "MAGNESIUM HYDROXIDE", "strength": "135 mg/5mL"}], "application_number": "M001", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20170601", "listing_expiration_date": "20261231"}